Alnylam Canada ULC is pleased to announce that GIVLAARI® (givosiran injection) is now funded across Canada through both public and private insurance plans for patients living with acute hepatic ...

But a study published this year suggests up to 13 percent of people diagnosed with dementia in the US may have a misdiagnosis ...

Emerging evidence highlights the critical role of circadian dysfunction in MASLD pathogenesis. The circadian rhythm, ...

A research team investigates how mushroom extract AHCC could prevent liver fibrosis by targeting key mechanisms, with ...

The cross-sectional study analyzed the association of extra-hepatic comorbidities, alcohol, and smoking on HRQOL in patients with ALD. Patients with ALD were aged 16 years and older, and the ...

A newly published review in eGastroenterology compiles recent research on alcohol-associated liver disease (ALD), offering an overview of its pathogenesis and efforts to better understand this ...

Chronic liver damage can lead to hepatitis, which causes fibrosis of the liver. This buildup of collagen and other fibrous ...

A recent review published in eGastroenterology discusses recent advancements in understanding alcohol-associated liver ...

A study in mice indicates that a shiitake extract may help suppress liver fibrosis through two different pathways.

The prescribing information for Veozah (fezolinetant) has been updated to include a boxed warning regarding the risk of hepatotoxicity, following the Food and Drug Administration’s review of a ...

DA-1241 Demonstrated Direct Hepatic Action in Addition to Its Glucose Lowering EffectPatients Treated with DA-1241 100mg Achieved Statistically Significant Reduction in ALT Levels at Weeks 4 and 8, ...

US Food and Drug Administration (USFDA) has added a boxed Warning highlighting the known risk of rare but serious liver ...